IIM
LXEO icon

INTECH Investment Management’s Lexeo Therapeutics LXEO Stock Holding History

INTECH Investment Management’s Portfolio LXEO Stock Details LXEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$94.7K Buy
16,504
+2,316
+16% +$16.4K ﹤0.01% 1904
2025
Q4 		$141K Buy
14,188
+2,317
+20% +$21.1K ﹤0.01% 2089
2025
Q3 		$78.8K Sell
11,871
-1,811
-13% -$8.76K ﹤0.01% 2313
2025
Q2 		$55K Buy
13,682
+2,342
+21% +$7.7K ﹤0.01% 2411
2025
Q1 		$39.4K Sell
11,340
-225
-2% -$997 ﹤0.01% 2454
2024
Q4 		$76.1K Buy
+11,565
New +$91.1K ﹤0.01% 2267

Other funds holding LXEO

PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

INTECH Investment Management's LXEO Position: Q1 2026 in Review

INTECH Investment Management increased its Lexeo Therapeutics (LXEO) stake by 16% in Q1 2026, buying an estimated $16.4K and bringing the position to 16,504 shares worth $94.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1904.

INTECH Investment Management first reported a position in LXEO in Q4 2024 and has held it in 6 quarters since. The position peaked at $141K in Q4 2025. 139 funds tracked by Wall St. Rank hold LXEO as of Q1 2026.

  • INTECH Investment Management held 16,504 shares of Lexeo Therapeutics worth $94.7K as of Q1 2026.
  • INTECH Investment Management bought 2,316 Lexeo Therapeutics shares in Q1 2026, an estimated $16.4K.
  • Lexeo Therapeutics made up ﹤0.01% of INTECH Investment Management's portfolio in Q1 2026, its #1904 holding.
  • INTECH Investment Management first reported a position in Lexeo Therapeutics in Q4 2024 and has held it in 6 quarters since.
  • INTECH Investment Management's Lexeo Therapeutics position peaked at $141K in Q4 2025.
  • 139 funds tracked by Wall St. Rank held Lexeo Therapeutics as of Q1 2026.

Based on INTECH Investment Management's 13F filing for Q1 2026, filed 8 May 2026.